Gemcitabine and Cisplatin in Treating Patients With Refractory or Recurrent Cancer of the Cervix
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of combining gemcitabine and cisplatin in
treating patients who have refractory or recurrent cancer of the cervix.